BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXWGet Free Report) saw a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 100 shares, a decrease of 95.8% from the April 30th total of 2,400 shares. Based on an average daily volume of 41,000 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Price Performance

Shares of BCTXW traded up $0.01 during trading hours on Wednesday, reaching $0.52. The company’s stock had a trading volume of 49,577 shares, compared to its average volume of 29,533. BriaCell Therapeutics has a 1-year low of $0.33 and a 1-year high of $3.30. The company has a 50 day moving average of $0.96 and a two-hundred day moving average of $1.49.

About BriaCell Therapeutics

(Get Free Report)

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.

Featured Articles

Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.